Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice: Ha Young Ju, Jongwan Kim, Sang Jun Han; Kidney Res Clin Pract. 2023;42(3):325-339. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.034
Web of Science 3 Cited By 3; Full text PubReader ePub PDF

Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice: Yosep Kim, Jongwan Kim, Sang Jun Han; Kidney Res Clin Pract. 2023;42(2):188-201. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.033
Cited By 1; Full text PubReader ePub PDF

Review Articles

Healthy aging and chronic kidney disease: Reshma Aziz Merchant, Anantharaman Vathsala; Kidney Res Clin Pract. 2022;41(6):644-656. Published online October 25, 2022; DOI: https://doi.org/10.23876/j.krcp.22.112
Web of Science 7 Cited By 6; Full text PubReader ePub PDF

Diabetic kidney disease treatment: new perspectives: Li-Li Tong, Sharon G. Adler; Kidney Res Clin Pract. 2022;41(Suppl 2):S63-S73. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.21.288
Web of Science 6 Cited By 6; Full text PubReader ePub PDF

Original Articles

Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people: Shin Chan Kang, Hee Byung Koh, Hyung Woo Kim et al.; Kidney Res Clin Pract. 2022;41(6):753-763. Published online September 8, 2022; DOI: https://doi.org/10.23876/j.krcp.21.311
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Review Articles

Adenosine receptors as emerging therapeutic targets for diabetic kidney disease: Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha; Kidney Res Clin Pract. 2022;41(Suppl 2):S74-S88. Published online August 22, 2022; DOI: https://doi.org/10.23876/j.krcp.22.011
Web of Science 3 Cited By 3; Full text PubReader ePub PDF

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors: Anthony T. P. Chan, Sydney C. W. Tang; Kidney Res Clin Pract. 2022;41(6):682-698. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.21.285
Web of Science 4 Cited By 3; Full text PubReader ePub PDF

Original Articles

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease: Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song; Kidney Res Clin Pract. 2022;41(5):580-590. Published online June 24, 2022; DOI: https://doi.org/10.23876/j.krcp.21.214
Web of Science 9 Cited By 10; Full text PubReader ePub PDF Supplementary Material

Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against chronic kidney disease patients: Maria Korogiannou, Marieta Theodorakopoulou, Pantelis Sarafidis et al.; Kidney Res Clin Pract. 2022;41(4):482-491. Published online June 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.250
Web of Science 5 Cited By 5; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 5 Cited By 6; Full text PubReader ePub PDF

Albuminuria, estimated glomerular filtration rate, and traditional predictors for composite cardiovascular and kidney outcome: a population-based cohort study in Korea: Hae Hyuk Jung; Kidney Res Clin Pract. 2022;41(5):567-579. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.22.005
Web of Science 2 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Review Articles

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 8 Cited By 10; Full text PubReader ePub PDF

Application of C5 inhibitors in glomerular diseases in 2021: Alexis Werion, Eric Rondeau; Kidney Res Clin Pract. 2022;41(4):412-421. Published online March 15, 2022; DOI: https://doi.org/10.23876/j.krcp.21.248
Web of Science 11 Cited By 13; Full text PubReader ePub PDF

Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction: Kunitoshi Iseki; Kidney Res Clin Pract. 2022;41(6):657-669. Published online January 21, 2022; DOI: https://doi.org/10.23876/j.krcp.21.203
Web of Science 5 Cited By 7; Full text PubReader ePub PDF

Special Article

Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector: Joyita Bharati, Vivekanand Jha; Kidney Res Clin Pract. 2022;41(1):22-30. Published online January 13, 2022; DOI: https://doi.org/10.23876/j.krcp.21.236
Web of Science 7 Cited By 9; Full text PubReader ePub PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,021	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,936	C4d Puzzle in ABO-incompatible kidney transplantation
8,427	How should we treat acute kidney injury caused by renal congestion?
13,150	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,278	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.